Skip to main content

Table 1 Baseline characteristics in the C and F group

From: Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series

Characteristics

Descriptive statistics

C group

F group

Df

P Value

Case number

n

120

32

  

Age

Mean ± SD

51.89 ± 10.96

56.47 ± 11.36

150

0.039a

 

Range

22–79

31–81

Gender

   

1

0.844c

 Male

n (%)

92 (76.7%)

24 (75.0%)

 Female

n (%)

28 (23.3%)

8 (25.0%)

Period of pain (months)

n

86

17

–

0.098b

 

Median (Interquartile range)

18 (12–26.5)

13 (5.5–24)

 

Range

1–102

1–72

ADV total treatment time (months)

n

115

30

–

0.939b

 

Median (Interquartile range)

60 (36–72)

57 (38–69)

 

Range

5–144

9–132

ADV treatment time of pain onset (months)

n

87

22

–

0.153b

 

Median (Interquartile range)

36 (24–48)

47.5 (28–60)

 

Range

2–95

1–90

BMI (kg/m2)

n

8

5

11

0.192a

 

Mean ± SD

21.21 ± 1.85

23.44 ± 3.98

 

Range

19.53–24.70

18.00–28.00

Initial time of pain relief (months)

n

76

20

–

0.003b

 

Median (Interquartile range)

1.5 (1–2)

3 (2–6)

 

Range

0.3–6.0

0.5–18.0

Initial time of serum Phos. Rising (months)

n

53

11

–

0.115b

 

Median (Interquartile range)

2 (1–3)

3.5 (1.75–6)

 

Range

0.3–12.0

0.5–11.0

  1. ADV Adefovir Dipivoxil, BMI body mass index, Phos. phosphate
  2. aTwo independent sample t test
  3. bTwo independent sample Mann-Whitney U test
  4. c Fisher’s exact test